Antibody Reagent Spotlight - Generating positive control antibodies for your Anti-Drug Antibody (ADA) assay

Biotherapeutics have been on the center stage in the pharmaceutical industry portfolios and accounted for almost one-half of recent new drug approvals. The majority of these products are monoclonal antibodies (mAbs), recombinant proteins, hormones, cytokines, growth factors, gene therapy products and gene-silencing/editing therapies. The potential immunogenicity of biological products results in the elicitation of anti-drug antibodies (ADA). This undesired immune response is an important safety concern for biopharmaceutical industry and regulatory authorities.

Copy and paste this URL:

https://biopharma.labcorp.com/latest-thinking/explore-library/detail.html/covance/assetLibrary/Blog/4-29-2021%201-41-41%20PM.jpg